BioCentury
ARTICLE | Clinical News

Micafungin antifungal regulatory update

July 8, 2002 7:00 AM UTC

Fujisawa’s Fujisawa Canada Inc. subsidiary submitted an NDS for Canadian marketing approval for its Micafungin to treat fungal infections. Micafungin is an echinocandin that inhibits cell wall synthes...